Seshu K. Kanneganti

The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity

Simak Ali, Dean A. Heathcote, Sebastian H. B. Kroll et al. · Cancer Research · 2009 · 162 citations · Full text

A Novel Pyrazolo[1,5-<i>a</i>]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration

Dean A. Heathcote, Hetal Patel, Sebastian H. B. Kroll et al. · Journal of Medicinal Chemistry · 2010 · 99 citations · Full text

Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis

Marie-José Bijlmakers, Seshu K. Kanneganti, Juliet N. Barker et al. · Human Molecular Genetics · 2011 · 85 citations · Full text

Engineering, Innate Immune System, Immunology +26

Aminoglycoside-mediated promotion of translation readthrough occurs through a non-stochastic mechanism that competes with translation termination

Hasnin M. Chowdhury, Aarif Siddiqui, Seshu K. Kanneganti et al. · Human Molecular Genetics · 2017 · 22 citations · Full text

Selenocysteine Insertion Sequence, Translation Readthrough, Molecular Biology +17